Table 3 Univariate and multivariate analyses of risk factors for pretreatment thrombocytosis.
Factors | Platelet counts (×103/ mm3) | Univariate | Mutivariate | ||||
|---|---|---|---|---|---|---|---|
< 400 (n = 88) | ≥ 400 (n = 38) | OR (95% CI) | P | OR (95% CI) | P | ||
Microcytic hypochromic anemia | 0.0022 | 0.0091 | |||||
Present | 4 (4.6%) | 7 (18.4%) | 7.56 (2.04–36.23) | 6.52 (1.57–36.73) | |||
Absent | 84 (95.4%) | 31 (81.6%) | Ref | Ref | |||
FIGO stage | 0.028 | 0.15 | |||||
I/ II | 17 (19.3%) | 2 (5.3%) | Ref | Ref | |||
III/ IV | 71 (80.7%) | 36 (94.7%) | 4.31 (1.15–28.12) | 2.84 (0.72–18.95) | |||
Histologic subtype | 0.061 | – | |||||
Serous | 47 (53.4%) | 27 (71.1%) | 2.41 (0.97–5.00) | – | |||
Others* | 41 (46.6%) | 11 (28.9%) | Ref | – | |||
Operation achievement | 0.89 | – | |||||
Complete, Optimal | 78 (88.6%) | 34 (89.5%) | Ref | – | |||
Suboptimal | 10 (11.4%) | 4 (10.5%) | 0.92 (0.24–2.96) | – | |||
Non-malignant inflammatory condition | 0.041 | 0.17 | |||||
Present | 4 (4.6%) | 6 (15.8%) | 3.94 (1.06–16.27) | 2.67 (0.085–1.56) | |||
Absent | 84 (95.4%) | 32 (84.2%) | Ref | Ref | |||
TFI (months) | Mean ± SD | 16.5 ± 23.03 | 8.30 ± 7.31 | 0.003 (0.00–0.30) | 0.0091 | 0.0095 (0.00–0.75) | 0.021 |